MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

11 Feb 2026 Evaluate
The sales declined to Rs. 1646.81 millions for the December 2025 quarter as compared to Rs. 1795.94 millions during the corresponding quarter last year.Net profit declined -11.61% to Rs. 186.07 millions from Rs. 210.51 millions.Operating profit for the quarter ended December 2025 decreased to 370.82 millions as compared to 373.94 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1646.81 1795.94 -8.30 5182.70 5112.03 1.38 6672.05 6054.60 10.20
Other Income 102.32 116.61 -12.25 466.70 285.95 63.21 362.16 335.01 8.10
PBIDT 370.82 373.94 -0.83 1243.05 1047.10 18.71 1278.02 1406.68 -9.15
Interest 14.75 6.68 120.81 93.02 52.84 76.04 65.84 58.06 13.40
PBDT 330.93 367.26 -9.89 1124.89 994.26 13.14 1212.18 937.76 29.26
Depreciation 78.02 69.57 12.15 231.79 196.13 18.18 270.47 235.19 15.00
PBT 252.91 297.69 -15.04 893.10 798.13 11.90 941.71 702.57 34.04
TAX 66.84 87.18 -23.33 248.58 222.98 11.48 252.03 196.13 28.50
Deferred Tax -8.38 -15.53 -46.04 -66.23 -37.45 76.85 -47.89 -75.49 -36.56
PAT 186.07 210.51 -11.61 644.52 575.15 12.06 689.68 506.44 36.18
Equity 105.79 105.37 0.40 105.79 105.37 0.40 105.37 104.69 0.65
PBIDTM(%) 22.52 20.82 8.15 23.98 20.48 17.09 19.15 23.23 -17.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..